Search Results for 'hiv tenofovir'

hiv tenofovir published presentations and documents on DocSlides.

The Bangkok Tenofovir Study

The Bangkok Tenofovir Study

by marina-yarberry

An HIV pre-exposure prophylaxis trial in Thailand...

Switching the NRTI Backbone to Tenofovir DF-Emtricitabine

Switching the NRTI Backbone to Tenofovir DF-Emtricitabine

by reese

TOTEM. Switching the NRTI Backbone to Tenofovir DF...

HIV Medication Overview

HIV Medication Overview

by kittie-lecroy

John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. A...

HIV Pharmacotherapy Focused Update

HIV Pharmacotherapy Focused Update

by yoshiko-marsland

Drew Lambert, . PharmD. lambertd@husson.edu. Huss...

Antiretroviral Updates:

Antiretroviral Updates:

by tatyana-admore

New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...

Conflict of Interest “No conflicts of interest to declare”

Conflict of Interest “No conflicts of interest to declare”

by karlyn-bohler

Lessons Learned from Tenofovir Vaginal Gel Studie...

ART Initiation: PrEP and

ART Initiation: PrEP and

by alida-meadow

Treatment-naïve Patients . Clinical Instructor, ...

by pasty-toler

of the evidence from oral and topical . PrEP. ef...

by alida-meadow

based . PrEP. technologies in women : . what do...

Major Changes to the HHS Adult and Adolescent HIV Treatment

Major Changes to the HHS Adult and Adolescent HIV Treatment

by tawny-fly

Brian R. Wood, MD. Assistant Professor of Medicin...

Generic tenofovir disoproxil

Generic tenofovir disoproxil

by SunkissedBabe

fumarate and . emtricitabine. tablets obtained fr...

Switching from TDF/FTC to TAF/

Switching from TDF/FTC to TAF/

by fanny

FTC. Study 311-1089. Switching from TDF/FTC to TAF...

HIV in Flux Viruses We’re talking tiny: 110 – 150 nm

HIV in Flux Viruses We’re talking tiny: 110 – 150 nm

by TacoBellDiego

That’s 150 billionths of a meter. The bad guy . ...

HIV OI's and prophylaxis

HIV OI's and prophylaxis

by callie

, PEP, PREP . Compiled by Jason Vermaak, . Ektha. ...

HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP

HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP

by Powerpixel

Clinical Pharmacist – HIV Medicine. Outline. Wha...

2014: HIV, HCV, and HBV

2014: HIV, HCV, and HBV

by kittie-lecroy

Update. David Spach, MD. Professor of Medicine,...

Pre-exposure Prophylaxis for HIV Prevention

Pre-exposure Prophylaxis for HIV Prevention

by pamella-moone

Efficacy and the importance of adherence. Joanne ...

Pre- and Post-Exposure Prophylaxis for HIV

Pre- and Post-Exposure Prophylaxis for HIV

by stefany-barnette

Kevin L. Ard, MD, MPH. October 20, 2016. Learning...

HIV Pharmacotherapy Focused Update

HIV Pharmacotherapy Focused Update

by sherrill-nordquist

Drew Lambert, . PharmD. lambertd@husson.edu. Huss...

by min-jolicoeur

with . Different Groups. Module 3 (f). People who...

Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of

Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of

by briana-ranney

B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Buku...

HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional

HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional

by mitsue-stanley

HBV Clinical Management [TRAINER(S) NAME(S)] IAPA...

Getting the FACTS Right!

Getting the FACTS Right!

by sophie

Update & Scenario Planning for FACTS001 Trial....

HBV Clinical Management [TRAINER(S) NAME(S)]

HBV Clinical Management [TRAINER(S) NAME(S)]

by mia

IAPAC African Regional . Capacity-Building . Hub. ...

Presenters Kathryn Burnett, PharmD, BCPS, BCIDP

Presenters Kathryn Burnett, PharmD, BCPS, BCIDP

by jade

Madeline Droney, PharmD. In it for the Long-Haul. ...

Cases from the Clinic(ians): Case-based Panel Discussion

Cases from the Clinic(ians): Case-based Panel Discussion

by tripp

Associate Dean for Global Health. University of Al...

Switching From a Tenofovir

Switching From a Tenofovir

by yael

. Disoproxil. . Fumarate. (TDF)-Based Regimen to...

Tenofovir Alafenamide (TAF)

Tenofovir Alafenamide (TAF)

by nicole

in a Single-Tablet Regimen . in Initial HIV-1 Ther...

The goal of hepatitis C virus (HCV) treatment is a cure (when there is

The goal of hepatitis C virus (HCV) treatment is a cure (when there is

by amey

Genotype 1, never treated for HCV, no cirrhosis12 ...

TENOFOVIR ALAFENAMIDE PHARMACOKINETICS

TENOFOVIR ALAFENAMIDE PHARMACOKINETICS

by studyne

WITH AND WITHOUT COBICISTAT IN PREGNANCY . Jeremia...

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

by phoebe-click

ACTIVITY CODE . TD342. Antiretroviral Medications...

Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, N

Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, N

by briana-ranney

Guidelines for Prevention and Treatment of Opport...

Projecting the Impact of

Projecting the Impact of

by marina-yarberry

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

New Prevention Technologies Workshop

New Prevention Technologies Workshop

by olivia-moreira

Module 5: . State of NPT Research. www.icad-cisd....

Managing Antiretroviral Failure in 2012

Managing Antiretroviral Failure in 2012

by sherrill-nordquist

Jennifer Hoy. , MBBS. Professor of Medicine. Dire...